GB201614485D0 - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
GB201614485D0
GB201614485D0 GBGB1614485.9A GB201614485A GB201614485D0 GB 201614485 D0 GB201614485 D0 GB 201614485D0 GB 201614485 A GB201614485 A GB 201614485A GB 201614485 D0 GB201614485 D0 GB 201614485D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic composition
immunogenic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1614485.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1614485.9A priority Critical patent/GB201614485D0/en
Publication of GB201614485D0 publication Critical patent/GB201614485D0/en
Priority to CA3034328A priority patent/CA3034328A1/en
Priority to PCT/GB2017/052510 priority patent/WO2018037246A1/en
Priority to US16/326,749 priority patent/US11123422B2/en
Priority to AU2017315238A priority patent/AU2017315238A1/en
Priority to JP2019511574A priority patent/JP7203015B2/ja
Priority to CN201780051719.XA priority patent/CN109923125B/zh
Priority to EP17758932.2A priority patent/EP3504235A1/en
Priority to US17/458,712 priority patent/US12390518B2/en
Priority to JP2022209044A priority patent/JP7762643B2/ja
Priority to AU2024227680A priority patent/AU2024227680A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C07K16/108—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB1614485.9A 2016-08-25 2016-08-25 Immunogenic composition Ceased GB201614485D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1614485.9A GB201614485D0 (en) 2016-08-25 2016-08-25 Immunogenic composition
EP17758932.2A EP3504235A1 (en) 2016-08-25 2017-08-25 Immunogenic composition
AU2017315238A AU2017315238A1 (en) 2016-08-25 2017-08-25 Immunogenic composition
PCT/GB2017/052510 WO2018037246A1 (en) 2016-08-25 2017-08-25 Immunogenic composition
US16/326,749 US11123422B2 (en) 2016-08-25 2017-08-25 Immunogenic composition
CA3034328A CA3034328A1 (en) 2016-08-25 2017-08-25 Immunogenic composition
JP2019511574A JP7203015B2 (ja) 2016-08-25 2017-08-25 免疫原性組成物
CN201780051719.XA CN109923125B (zh) 2016-08-25 2017-08-25 免疫原性组合物
US17/458,712 US12390518B2 (en) 2016-08-25 2021-08-27 Immunogenic composition
JP2022209044A JP7762643B2 (ja) 2016-08-25 2022-12-26 免疫原性組成物
AU2024227680A AU2024227680A1 (en) 2016-08-25 2024-10-28 Immunogenic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614485.9A GB201614485D0 (en) 2016-08-25 2016-08-25 Immunogenic composition

Publications (1)

Publication Number Publication Date
GB201614485D0 true GB201614485D0 (en) 2016-10-12

Family

ID=57119951

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1614485.9A Ceased GB201614485D0 (en) 2016-08-25 2016-08-25 Immunogenic composition

Country Status (8)

Country Link
US (2) US11123422B2 (enExample)
EP (1) EP3504235A1 (enExample)
JP (2) JP7203015B2 (enExample)
CN (1) CN109923125B (enExample)
AU (2) AU2017315238A1 (enExample)
CA (1) CA3034328A1 (enExample)
GB (1) GB201614485D0 (enExample)
WO (1) WO2018037246A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition
CN113423421A (zh) * 2018-09-21 2021-09-21 内布拉斯加大学董事会 制备和使用通用中心化流感疫苗基因的方法
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
GB202204478D0 (en) * 2022-03-29 2022-05-11 Univ Oxford Innovation Ltd Immunogenic compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
CA2035576A1 (en) 1990-02-07 1991-08-08 Alexander R. Neurath Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 hiv-1
EP0851927B1 (en) * 1995-09-01 2003-10-22 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
US20080187557A1 (en) * 2005-04-11 2008-08-07 Suryaprakash Sambhara Vaccine Against Pandemic Strains Of Influenza Viruses
JP2009537147A (ja) 2006-05-15 2009-10-29 シー レーン バイオテクノロジーズ， エルエルシー インフルエンザウイルスに対する中和抗体
AU2007286161B2 (en) * 2006-08-09 2013-05-02 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
CN102165062B (zh) 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
CN102939102A (zh) * 2010-04-09 2013-02-20 乌得勒支大学控股有限责任公司 重组多聚流感蛋白
CA2807664A1 (en) * 2010-08-12 2012-02-16 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
US8883171B2 (en) 2010-09-14 2014-11-11 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for influenza
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
US9637522B2 (en) * 2012-05-23 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Influenza vaccine constructs
US8932598B2 (en) * 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
KR102199018B1 (ko) 2013-03-28 2021-01-07 메디카고 인코포레이티드 식물에서 인플루엔자 바이러스-유사 입자 생산
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Also Published As

Publication number Publication date
JP2019534242A (ja) 2019-11-28
US12390518B2 (en) 2025-08-19
WO2018037246A4 (en) 2018-04-19
JP2023052092A (ja) 2023-04-11
AU2017315238A1 (en) 2019-02-21
JP7762643B2 (ja) 2025-10-30
US20220054625A1 (en) 2022-02-24
WO2018037246A1 (en) 2018-03-01
JP7203015B2 (ja) 2023-01-12
CN109923125A (zh) 2019-06-21
US11123422B2 (en) 2021-09-21
CN109923125B (zh) 2024-05-31
CA3034328A1 (en) 2018-03-01
EP3504235A1 (en) 2019-07-03
AU2024227680A1 (en) 2024-11-21
US20190201521A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
GB201711635D0 (en) Immunogenic composition
GB201610599D0 (en) Immunogenic Composition
IL271603A (en) Immunogenic preparations
EP3397277C0 (en) IMMUNOGENIC COMPOSITION
GB201711637D0 (en) Immunogenic composition
GB201614485D0 (en) Immunogenic composition
GB201612658D0 (en) Composition
GB201604755D0 (en) Immunogenic compositions
GB201617908D0 (en) Composition
GB201611782D0 (en) Composition
GB201703529D0 (en) Vaccine composition
GB201616654D0 (en) Composition
GB201612359D0 (en) Composition
GB201911959D0 (en) Immunogenic compositions and uses therefor
GB201615908D0 (en) Pharmaceautical composition
GB201607924D0 (en) Composition
HK40007612A (en) Immunogenic composition
GB201411371D0 (en) Immunogenic composition
GB201411306D0 (en) Immunogenic composition
GB201618062D0 (en) Composition
GB201616772D0 (en) Composition
GB201616785D0 (en) Composition
GB201611084D0 (en) Vaccine compositions
GB201615463D0 (en) Composition
GB201615461D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)